View all Press Releases

Acerus to Report Third Quarter 2018 Financial Results and Host Investor Call

10/30/2018

TORONTO--(BUSINESS WIRE)-- Acerus Pharmaceuticals Corporation (TSX:ASP) will announce its third quarter 2018 financial and operating results on Tuesday November 6, 2018 before market opens. The company will host a conference call on Tuesday, November 6, 2018 at 8:30 a.m. Eastern Time.

To access the call live, please dial 416-340-2216 or 1-800-377-0758. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference call will be available until 11:59 p.m. Eastern Time on Tuesday, November 13, 2018 by dialing 905-694-9451 or 1-800-408-3053, using access code: 9812622#.

About Acerus

Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, branded products that improve patient experience, with a primary focus in the field of men’s and women’s health. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S. and other territories.

Acerus’ shares trade on Toronto Stock Exchange under the symbol “ASP”. For more information, visit www.aceruspharma.com and follow us on Twitter and Linkedin.

Acerus Pharmaceuticals Corporation
Ed Gudaitis, (905) 817-8194
President & CEO
egudaitis@aceruspharma.com

Source: Acerus Pharmaceuticals Corporation